Neylan John F. 4
4 · Angion Biomedica Corp. · Filed Mar 19, 2021
Insider Transaction Report
Form 4
Neylan John F.
See Remarks
Transactions
- Sale
Common Stock
[F1]2021-03-17$19.13/sh−442$8,455→ 38,453 total
Footnotes (1)
- [F1]The shares were sold to the Issuer solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a Restricted Stock Awards ("RSAs") of the Issuer.
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for John F. Neylan|2021-03-19